AHCSAamal Company

🇶🇦 QSE
0.70
QAR
Analysis Scores
Lothien Robustness Score?
66/100
Strong
Neden bu skor?
Damodaran ?
44/100
Dalio Risk ?
79/100
Piotroski ?
3/9
Weak
Operating cash flow data missing (C3, C4)
Graham ?
QAR1.4
Ucuz
Active Metric?
4/4
Confidence?
72%
Valuation
Potential?
+33.5%
ROIC ?
3.6%
DCF Value ?
0.63
Debt Cycle?
Early Expansion
Data
Data ?
4142
2010-02-22 → 2026-09-02
Risk Analysis (VaR) Düşük
252 days
Annual Volatility ?
%17.2
VaR 95% ?
%1.84
daily max loss
VaR 99% ?
%2.58
daily max loss
CVaR 95% ?
%2.99
expected loss (tail)
Max Drawdown ?
%21.8
18.02.2026 → 26.08.2026
Skewness ?
-2.91
Parametrik%1.84
Historik%1.69
Cornish-Fisher%2.07
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Near TRAMA
Price (0.70), TRAMA-99 line (0.74) at close levels (%-4.7). Important decision zone — breakout direction will determine the trend.
Price:: 0.704
TRAMA: 0.7386
Difference: %-4.7
Profitability
Net Profit Margin %22.2
Net profit margin %22.2 — very strong. Compared to previous quarter +0.0 point increase.
ROE – Özkaynak Getirisi (TTM) %4.0
ROE %4.0 — low return on equity.
EBITDA Margin %25.8
EBITDA margin %25.8 — operationally very efficient.
Gross Profit Margin %25.8
Gross profit per revenue %25.8. Evaluate relative to sector.
Valuation
P/E Ratio 10.0x Sector: 13.0x
F/K 10.0x — sector medianna (13.0x) near reasonable levels.
P/B Ratio 0.53x Sector: 1.44x
PD/DD 0.53x — sector median's (1.44x) çok below. Defter değerine göre undervalued.
EV/EBITDA 10.7x Sector: 9.0x
EV/EBITDA 10.7x — sector median's (9.0x) %19 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio 1.97x
Current ratio 1.97x — can comfortably cover short-term debts.
Net Debt / EBITDA 1.8x
Net Borç/EBITDA 1.8x — manageable debt level.
Debt / Equity 0.10x
Low leverage — majority of assets financed by equity.
Interest Coverage 22.8x
Interest coverage 22.8x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+0.0
Revenue YoY %0.0 declined — slight decrease, monitor closely.
Net Profit Growth (YoY) %+0.0
Net profit YoY %0.0 declined — profitability under pressure.
Seasonality Analysis Q3 (Tem-Eyl)
Historically strongest quarter: Q3 (Jul-Sep) (avg. profit 112.4M). Weakest quarter: Q4 (Oct-Dec) (avg. profit 110.8M).
Score Explanations
Lothien Robustness
66/100
Good robustness (66/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+33.5%
Plus %33.5 expected value (0.94) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %72.
Components: PE target: 0.91 | P/B target: 1.94 | EV/EBITDA target: 0.59 | DCF target: 0.63
Damodaran Valuation
44/100
Low Damodaran score (44/100). ROIC (%3.6) below cost of capital. DCF analysis does not support current price.
Weak
Dalio Risk Analysis
79/100
Low debt risk (79/100). Interest coverage ratio 22.8x — strong. Borç/EBITDA 1.8x — in healthy range.
Leverage: 87/100 | Debt Service: 99/100 | Quality: 87/100
ROIC – Sermaye Getirisi
%3.6
ROIC (%3.6) cost of capitaln (11.5%) below → destroying value.
WACC: %11.5
DCF Discounted Cash Flow
0.63
DCF (0.63) current price %11.0 below — cash flows do not support current price.
Current price: 0.70
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
3/9
Weak Piotroski (3/9). Many balance sheet quality criteria not met. Note: Operating cash flow data missing (C3, C4)
Weak
Graham Intrinsic Value
QAR1.4
Graham intrinsic value: QAR1.4. Ucuz
Cheap
⚖️ Sector Comparison
P/E Ratio
10.0x vs 13.0x
Sector mediannın %23 below — cheap
P/B Ratio
0.53x vs 1.44x
Compared to sector %63 cheaper (by book value)
EV/EBITDA
10.7x vs 9.0x
Compared to sector %19 higher EV/EBITDA
ROIC vs WACC
%3.6 vs %11.5 WACC
ROIC 7.9 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%22.2 vs %23.9 EBITDA margin
TTM net profit margin %22.2
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
AHCS — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.
A
AirSelim
Online
A
Hello! I am AirSelim, your Lothien finance assistant.

I can answer questions about market data, news, technical analysis, portfolio analysis and more.

I cover 26 exchanges (BIST, US, LSE, Xetra, Tadawul, KASE and others) — plus crypto.